Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Infections News
Wheezing occurs less in children born during COVID-19 lockdown vs. pre-pandemic
Wheezing at 30 months was less frequent in children born during vs. before the COVID-19 lockdown, according to a research letter published in JAMA Network Open.
Cystic fibrosis triple therapy improves lung ventilation, morphology in children
Lung clearance index and MRI scores improved in kids aged 6 to 11 years with cystic fibrosis and at least one F508del allele receiving elexacaftor/tezacaftor/ivacaftor therapy, according to results published in European Respiratory Journal.
Log in or Sign up for Free to view tailored content for your specialty!
Race-neutral lung function equations change spirometry interpretation in children
Following use of race-neutral vs. -specific lung function equations, spirometry findings and patterns differed, especially among Black children/adolescents, according to results published in JAMA Pediatrics.
More real-world evidence shows nirsevimab protects infants against RSV
The monoclonal antibody nirsevimab reduced the risk that infants would be hospitalized for respiratory syncytial virus-associated bronchiolitis, according to a study published Wednesday in The New England Journal of Medicine.
Childhood air pollutant exposures raise odds for adult bronchitic symptoms
Individuals exposed to nitrogen dioxide and particulate matter less than 10 µm as a child faced elevated odds for bronchitic symptoms as an adult, according to results published in American Journal of Respiratory and Critical Care Medicine.
Should the CDC do away with shared clinical decision-making?
Rather than telling a patient they should get a vaccine, the CDC’s shared clinical decision-making recommendations advise patients to speak to providers about certain vaccines and decide on an individual basis if they should receive them.
US gives Moderna $176 million to develop mRNA pandemic flu vaccine
HHS announced that it will give Moderna around $176 million to accelerate the development of a messenger RNA-based pandemic influenza vaccine amid an ongoing outbreak of avian influenza.
Will new approvals, stronger recommendations improve RSV vaccine uptake?
After decades of RSV vaccine development, the approvals and recommendations were seen as landmark events in preventive medicine. Uptake was low, however — not unusual for first-year approvals, experts told Healio.
CDC recommends new COVID-19, pneumococcal vaccines
The CDC on Thursday recommended updated COVID-19 vaccines for the 2024-2025 respiratory season, and a newly approved 21-valent pneumococcal conjugate vaccine for adults.
Children with MIS-C or COVID-19 and severe neuro symptoms face long-term impairment risk
Children hospitalized with SARS-CoV-2 or an inflammatory syndrome associated with SARS-CoV-2 infection who experience severe neurological manifestations may be at a higher risk for long-term impairment, a study found.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read